Google Übersetzer
Eton Pharmaceuticals Inc
About
Eton Pharmaceuticals Inc (NASDAQ:ETON) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
Apr 16 2026
Eton Pharmaceuticals Announces CFO Succession Plan
Mar 19 2026
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 3 2026
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
Mar 2 2026
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
Recent Videos
Eton Pharmaceuticals Q4 2025 Earnings Call | Rare Disease Sales Surge 83% as Portfolio Scales
Mar 29, 2026
Eton Pharmaceuticals Inc. 2025 annual report
Mar 21, 2026
Eton Pharmaceuticals Stock Analysis: High-Growth Rare Disease Revenue Expansion
Feb 20, 2026
Eton Pharmaceuticals stock | ETON stock price | ETON stock today | Eton share price | ETON stock
Jan 20, 2026
Financials
Revenue
$79.95 M
Market Cap
$682.11 M
EPS
-0.17